An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL)

Peter Borchmann, Constantine S. Tam, U. Jaeger, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael Bishop, Charalambos Andreadis, S.R. Foley,

Kölner Universitäts PublikationsServer (Universität zu Köln) · 2018 · 23 citations · 0 references

Concepts